louisakewell, Author at European Medical Journal - Page 92 of 153

Continue
EMJ
21 Oct 2015

Pacemakers Identify Atrial Fibrillation and Enable Initiation of Stroke Prevention

Vienna, Austria – 17 October 2015: Pacemakers identify atrial fibrillation and enable initiation of anticoagulation to prevent strokes, according to…
EMJ
20 Oct 2015

Childhood Infections Associated with Increased Risk of Early Heart Attack

Vienna, Austria – 17 October 2015: Infections in childhood are associated with an increased risk of early heart attacks, according to research presented…
EMJ
19 Oct 2015

Low Physical Activity Responsible for 17% of Cardiovascular Deaths in Argentina

Buenos Aires, Argentina, 15 October 2015: Low levels of physical activity are responsible for 17% of cardiovascular deaths in Argentina, reveals research…
EMJ
19 Oct 2015

Progress Made in New(t) Treatment for Osteoarthritis Patients

EXTRAORDINARY progress has been made towards developing effective stem cell treatment for osteoarthritis. Inspired by the ability of animals…
EMJ
19 Oct 2015

Rheumatoid Arthritis Therapy Approved By NICE

BIOLOGIC monotherapy RoActemra has been issued with a positive Final Appraisal Determination by the National Institute for Health and…
EMJ
15 Oct 2015

New approaches to molecular cancer therapeutics

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
EMJ
15 Oct 2015

The Patient Reported Opinions about Clinical Tolerability (PROACT)

At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient…
EMJ
15 Oct 2015

EURECCA international comparison of treatment patterns for non-metastatic breast cancer

At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…
EMJ
15 Oct 2015

Results from the ETOP Lungscape Project: Multiplex mutation testing in NSCLC

At the European Cancer Congress (ECC) 2015, Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen, Aberdeen, Scotland, discusses the…
EMJ
15 Oct 2015

The causes and consequences of tumour evolution and heterogeneity

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…